维普期刊资源整合服务平台（V6.5）

80篇 您的检索式：作者名="RASI G"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Drug policy for an aging population - the European Medicine Agency' s geriatric medicines strategy 显示文摘	Cerreta F Eichler HG Rasi G	2012	N EnglJMed2012，367，21：	1
2	Combined treatment with thymosin a l and low-dose interferon alpha after dacarbazine in advanced melanoma显示文摘	Rasi G Terzoli E Izzo F	2000	Melanoma Res2000，10，2：	1
3	Combination therapy in the treatment of chronic viral hepatatitis and prevention of hepatocellular carcinoma 显示文摘	Rasi G Pierimarchi P Sinibaldi Vallebona P	2003	Int Immunopharmacol2003，3，8：	1
4	Anti-tumor effect of combined treatment with thymosin alpha 1 and interlerkin-2 after 5-fluofouracil in liver metastases from colorectal cancer in rats 显示文摘	Silecchia G Sinibaldi VP	1994	Int J Cancer1994，57，5：	1
5	Analysis of the chronic lymphocytic leukemia coding genome:role of NOTCH1mutational activation显示文摘	FABBRI G RASI S ROSSI D	2011	J Exp Med2011，208，：	1
6	Combined treatment with thymosin-alapha 1 and low-dose interferon-alapha after ifosfamide in non-small cell lung cancer:a phase-Ⅱcontrolled trial显示文摘	Salvati F Rasi G Portalone L	1996	Anticancer Res1996，16，2：	1
7	Combined treatment with thymosin α 1 and low-dose interferon alpha after dacarbazine in advanced melanoma 显示文摘	Terzoli E Izzo F	2000	Melanoma Res2000，10，2：	1
8	Thymosina in the treatment of cancer:, from basic research to clinical application显示文摘	Garaci E Pica F Rasi G	2000	Int J Immunopharmaco12000，22，12：	1
9	Mutations of NOTCH1are an independent predictor of survival in chronic lymphocytic leukemia显示文摘	ROSSI D RASI S FABBRI G	2012	Blood2012，119，：	1
10	Combined treatment with thymosin-alpha 1 and low-dose interferon alpha after ifosfamide in non-small cell lung cancer: a phase-Ⅱ controlled trial 显示文摘	Rasi G Portalone L	1996	Anticancer Res1996，16，2：	1
11	Thymosinalpha-1 in the treatment of cancer: from basic research to clinical application显示文摘	Garaci E Pica F Rasi G	2000	Int lmmunopharmacol2000，22，12：	1
12	Oombined treatment with thymosin-alpha 1 and low dose interferon alpha after ifosfam ide in non small cell lung cancer: A phase contro lied trial显示文摘	Salvati F Rasi G Po rtalone L	1996	Anticancer Res1996，16，2：	1
13	Combined treatment with thymosin-alphal and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer:a phase-]] con- trolled trial显示文摘	Salvati F Rasi G Portalone L	1996	Anticancer Res1996，16，2：	1
14	Combination low-dose lymphoblastoid interferon and thymosin α 1 therapy in the treatment of chronic hepatitis B 显示文摘	Mutchnick MG Di Virgilio D	1996	J Viral Hepat1996，3，4：	1
15	Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application显示文摘	Garaci E Pica F Rasi G	2000	Int Immunopharmacol2000，22，12：	1
16	Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 显示文摘	Rasi G Pierimarchi P Sinibaldi Vallebona P	2003	Int Immunopharmacol2003，3，8：	1
17	Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application显示文摘	Garaci E Pica F Rasi G	2000	Int Immunopharmacol2000，22，12：	1
18	Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma显示文摘	Rasi G Pierimarchi P Sinibaldi Vallebona P	2003	Int Immunopharmacol2003，3，8：	1
19	Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastasis from colorectal cancer in rats显示文摘	Rasi G Silecchia G Sinibaldi-Vallebona P	1994	Int J Cancer1994，57，5：	1
20	Combination therapy with BRMs in cancer and infectious diseases 显示文摘	Garaci E Pica F Rasi G	1997	Mech Ageing Dev1997，96，13：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示